What ingredients are listed in Gelatide’s proprietary blend and what are the known interactions or dosing standards for each?
Executive summary
Publicly available pages that claim to describe Gelatide list a long, mixed roster of botanicals, cofactors and amino acids — including raspberry ketones, green tea extract, guarana, maca, ginseng, capsicum, Coenzyme Q10, PQQ, alpha‑lipoic acid, berberine and gymnema — but those listings are presented inside a 200 mg “proprietary blend” and the product itself lacks consistent regulatory or label verification in independent records [1] [2] [3] [4]. Because the exact per‑ingredient amounts are not disclosed on that blend and published sources do not provide ingredient‑by‑ingredient dosing or interaction data for this formulation, it is not possible from the reporting to say which ingredients are present at efficacious or unsafe doses [1] [3] [5].
1. What the reporting actually lists as ingredients in Gelatide’s proprietary blend
Multiple consumer and promotional pages claim the Gelatide proprietary blend combines common weight‑loss botanicals — raspberry ketones, green tea extract, guarana, maca, ginseng and capsicum — alongside metabolic cofactors such as CoQ10, PQQ and alpha‑lipoic acid, and other agents like berberine and gymnema [1] [2] [6]. The same reporting repeatedly notes that the Supplement Facts shown on some pages present these as part of a single 200 mg proprietary blend, with chromium reported at 0.7 mcg on one label snippet [1] [3].
2. Why the 200 mg proprietary‑blend framing matters for dosing and interactions
Under U.S. supplement labeling rules described in the literature, companies may list a proprietary blend’s total weight without revealing individual ingredient quantities, which means consumers and researchers cannot determine individual doses from the label alone; the academic review of proprietary blends explains this framework and the information gap it creates [5]. Several reviewers highlight that cramming “over a dozen botanicals and several amino acids” into a 200 mg total makes it effectively impossible to know whether any ingredient reaches a dose that clinical studies used or to predict interactions [3] [1].
3. What the sources say about safety claims and official status
Official marketing pages for Gelatide assert the product is natural, made in U.S. facilities and safe to combine with other supplements, and emphasize metabolic benefits from ingredients like green tea and guarana [6] [7]. Independent and critical coverage counters that there is no verified FDA listing, no clear manufacturer traceable in public records for a product named “Gelatide,” and the marketing claims often carry the standard “not evaluated by the FDA” disclaimer [4] [3].
4. Where the reporting is silent — interactions and standard dosing for each ingredient
The assembled reporting does not provide per‑ingredient dosages for the named compounds (beyond the single total blend weight) and does not supply a systematic, ingredient‑by‑ingredient review of drug interactions or clinical dosing standards for this specific Gelatide product; therefore, authoritative statements about interactions or safe/effective doses for each listed ingredient in this formulation cannot be made from these sources [1] [2] [3] [5].
5. Practical implications and alternative viewpoints
Because the official pages promote the blend’s efficacy and safety [6] [7] while independent reviewers emphasize the red flags of under‑disclosed proprietary blends and implausibly small total weights [1] [3] [5], a reader must weigh promotional claims against labeling opacity: the promotional narrative asserts safety and synergy, but the regulatory and reviewer literature documents why that opacity prevents verification of dosing and interaction risk [6] [1] [5].
6. Bottom line from the available reporting
The reporting collates a long ingredient list attributed to Gelatide and confirms a 200 mg proprietary‑blend figure and an extremely low chromium figure on at least one label snippet, but because per‑ingredient amounts and independent regulatory registration for a product called “Gelatide” are not verifiably published in these sources, the question of what interactions might occur or what clinical dosing standards apply to each named ingredient remains unanswered by the available documents [1] [3] [4] [5].